SCHEMBL25833864

SCHEMBL25833864

CN1CCCC(C)(C(=O)OCc2ccccc2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24758766 0.89 ALDH1A1 (0.47)
SCHEMBL16488071 0.83 OPRM1 (0.51)
SCHEMBL12621202 0.83 ALDH1A1 (0.53)
SCHEMBL18692576 0.83 ALDH1A1 (0.53)
SCHEMBL20221555 0.82 ALDH1A1 (0.51)
SCHEMBL25304414 0.80 MEN1 (0.45)
SCHEMBL28751823 0.79 MEN1 (0.47)
SCHEMBL15914128 0.79 MEN1 (0.50)
SCHEMBL1467919 0.79 MEN1 (0.50)
SCHEMBL19968196 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250114305-A1 LIPIDIC COMPOUNDS, AND USES THEREOF SANOFI (FR) 2025-04-10 US disclosed
EP-4466248-A1 LIPIDIC COMPOUNDS, AND USES THEREOF Sanofi (FR) 2024-11-27 EP disclosed
CN-118829624-A Lipid compound and use thereof 赛诺菲 2024-10-22 CN disclosed
WO-2023135305-A1 LIPIDIC COMPOUNDS, AND USES THEREOF SANOFI (FR) 2023-07-20 WO disclosed
WO-2023135305-A1 LIPIDIC COMPOUNDS, AND USES THEREOF SANOFI (FR) 2023-07-20 WO disclosed